GENERAL ATLANTIC, L.P. Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$3.2T
Holdings
19
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (19 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XPXP, INC | 29,617,733 | $521.0B | 16.38% | |
| 2 | DLODLOCAL | 63,906,695 | $517.0B | 16.26% | |
| 3 | ALKTALKAMI | 17,186,985 | $489.5B | 15.39% | |
| 4 | ALHCALIGNMENT HEALTHCARE | 60,993,323 | $477.0B | 15.00% | |
| 5 | 8DTSQUARESPACE | 10,611,073 | $463.0B | 14.56% | |
| 6 | PHVSPHARVARIS | 7,531,252 | $141.6B | 4.45% | |
| 7 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $130.2B | 4.09% | |
| 8 | AKROAKERO THERAPEUTICS | 5,233,989 | $122.8B | 3.86% | |
| 9 | CNTACENTESSA PHARMACEUTICALS | 9,681,818 | $87.4B | 2.75% | |
| 10 | BLNDBLEND LABS | 19,132,440 | $45.2B | 1.42% | |
| 11 | IMCRIMMUNOCORE | 1,261,684 | $42.8B | 1.34% | |
| 12 | RPRXROYALTY PHARMA | 1,500,000 | $39.6B | 1.24% | |
| 13 | THRDTHIRD HARMONIC BIO | 2,958,762 | $38.5B | 1.21% | |
| 14 | RSKDRISKIFIED | 5,324,998 | $34.0B | 1.07% | |
| 15 | SLRNACELYRIN | 2,889,668 | $12.7B | 0.40% | |
| 16 | OPENOPENDOOR | 6,321,519 | $11.6B | 0.37% | |
| 17 | 5ZZ0WISH | 609,616 | $3.5B | 0.11% | |
| 18 | GROVGROVE COLLABORATIVE | 936,020 | $1.7B | 0.05% | |
| 19 | ADAGADAGENE | 264,000 | $807.8M | 0.03% |